Short-Term Neural Recovery after Treatment for Spinal Cord Injury Using AXONIC-REVIVE™
Acta medica Lituanica · 20.11.2026 · 33 (2) · 19
DOI: 10.15388/amed.2026.33.2.19 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta medica Lituanica, online erschienen am 20.11.2026. Verfasst von Ireneusz Siemionkowicz. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The study is aimed to determine whether the AXONIC-REVIVE™ multimodal strategy resulted in measurable neural recovery following spinal cord injury, as assessed by a combination of functional parameters, neuroimaging data and laboratory markers. The study was conducted at the Faculty of Medicine of the University of Medicine and Social Sciences (Kharkiv) from 3 March to 31 December 2025, where the effectiveness of the applied strategy following spinal cord injury was assessed based on changes in the motor and sensory deficits, muscle tone, functional independence, as well as changes in the electrophysiological indicators of neuromuscular transmission and reinnervation, diffusion tensor magnetic resonance imaging (DTI-МРТ) parameters of the conduction pathways, and concentrations of cerebrospinal fluid biomarkers of neurotrophic support, plasticity and glial response. The results showed that, by week 24, recovery was observed in both groups; however, it was more pronounced in the AXONIC-REVIVE™ group: the motor score increased by 18.6 points versus 11.2, the sensory score by 19.7 versus 11.0, spasticity decreased by 0.8 points compared to 0.3, functional independence increased by 20.7 points compared to 12.1, and an improved bladder control by week 24 was recorded in 57.1% of the patients in the main group compared to 32.1% in the control group. More favourable trends were also observed in electromyography (EMG) (F-wave latency decreased by 5.5 ms compared with 2.4 ms in the control group), diffusion tensor magnetic resonance imaging (fractional anisotropy increased by 0.09 versus 0.04) and cerebrospinal fluid biomarkers of neurotrophic support and plasticity compared with standard rehabilitation overall. Thus, up to week 24, the AXONIC-REVIVE™ multimodal strategy was associated with greater clinical and functional improvement compared with standard rehabilitation. The results obtained can be used by neurosurgeons, physiatrists and multidisciplinary teams in rehabilitation centres to justify comprehensive monitoring and the selection of combined approaches to neurorehabilitation following spinal cord injury in clinical practice and pilot protocols.
Zitieren
APA
Siemionkowicz, I. (2026). Short-Term Neural Recovery after Treatment for Spinal Cord Injury Using AXONIC-REVIVE™. Acta medica Lituanica, 33(2), 19. https://doi.org/10.15388/amed.2026.33.2.19
Vancouver
Siemionkowicz I. Short-Term Neural Recovery after Treatment for Spinal Cord Injury Using AXONIC-REVIVE™. Acta medica Lituanica. 2026;33(2):19. doi:10.15388/amed.2026.33.2.19
BibTeX
@article{Siemionkowicz2026,
author = {Siemionkowicz, Ireneusz},
title = {Short-Term Neural Recovery after Treatment for Spinal Cord Injury Using AXONIC-REVIVE™},
journal = {Acta medica Lituanica},
year = {2026},
volume = {33},
number = {2},
pages = {19},
doi = {10.15388/amed.2026.33.2.19}
}
EUVIMED